The Antitrust Authority on Monday said it was reviewing a policy that would allow it to tackle monopolies for price gouging.
Two years ago, the authority announced that it would go after companies that charge take advantage of their market power to overcharge for products. Companies with over 50% market share that charged over 20% of their production costs could be sued in class action lawsuits, though they would not be subject to criminal sanctions. It would also consider how similar products were priced abroad and the business risk in the industry.
Since then, however, the Authority ran into difficulties, and never put together a complete enforcement mechanism. It also said that developments since the 2014 ruling had reshaped its thinking.
While price gouging remains a clear negative consequence of market concentration, the Authority wrote in a release on the matter, it is no longer clear if it is an Antitrust issue.
Recently, a court hearing a case on Tnuva overcharging for cottage cheese released new guidance on the matter, which the Authority said may alter the approach.
Full Content: JPost
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas